What is Insulin Aspart?
Category: Prescription Drugs
Most popular types: Novolog NovoLog FlexPen NovoRapid Show all
See also: Insulin Aspart Protamine
Insulin aspart is a rapid-acting insulin used for the treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) to improve glycemic control.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 1 | 1347 | 35 | |
| Diabetes type 2 | 168 | 36 | |
| Cystic fibrosis-related diabetes | 9 | 2 | |
| Elevated blood sugar (hyperglycemia) | 5 | 1 | |
| General health | 2 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 9 | |
| Mild | 19 | |
| None | 44 |
Commonly reported side effects and conditions associated with Insulin Aspart
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 15 | |
| Weight gain | 6 | |
| Injection site pain | 2 | |
| Reactive hypoglycemia | 2 | |
| Chronic hyperglycemia | 1 | |
| Chronic kidney disease | 1 |
Dosages
Based on patients currently taking Insulin Aspart
| Dosage | Patients | Percentage |
|---|---|---|
| 5 daily | 1 | |
| 5 intl units three times daily | 1 | |
| 6 intl units three times daily | 1 | |
| 8 mg three times daily | 1 | |
| 12 other three times daily | 1 | |
| 24 mg three times daily | 1 | |
| 100 units twice daily | 1 | |
| 90 intl units three times daily | 1 | |
| 1400 units three times daily | 1 | |
| 9000 units daily | 1 |
Duration
Currently taking Insulin Aspart
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 2 years | 2 | |
| 2 - 5 years | 6 | |
| 5 - 10 years | 5 | |
| 10 years or more | 2 |
Stopped taking Insulin Aspart
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 | |
| 6 months - 1 year | 6 | |
| 1 - 2 years | 7 | |
| 2 - 5 years | 9 | |
| 5 - 10 years | 4 | |
| 10 years or more | 3 |
What people switch to and from
Patients started taking Insulin Aspart after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Insulin Lispro (Humalog) | 10 | |
| Insulin Glargine (Lantus) | 7 | |
| Insulin NPH (Novolin N) | 6 | |
| Metformin (Metformin ER) | 5 | |
| Insulin Regular (Humulin R) | 4 |
Patients stopped taking Insulin Aspart and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Insulin Lispro (Humalog) | 8 | |
| insulin detemir (Levemir) | 3 | |
| Insulin Glargine (Lantus) | 2 | |
| Insulin Regular (Humulin R) | 2 | |
| Dulaglutide (Trulicity) | 1 |
Last updated: